Mankind Pharma signs in-licensing deal for Insulin Aspart and Insulin Degludec The Business Standard 12:14 Fri, 21 Aug
Stocks to watch: Tata Motors, Tata Power, Mankind Pharma, SBI, RailTel The Business Standard 03:45 Fri, 21 Aug
Mankind Pharma signs China pact to market insulin analogues in India The Business Standard 12:29 Thu, 20 Aug
Mankind Pharma inks in-licensing pact with China's Chongqing Chenan Biopharmaceutical The Economic Times 09:26 Thu, 20 Aug
Mankind Pharma inks in-licensing pact with China’s Chongqing Chenan Biopharmaceutical on two insulin analogues The Hindu Business Line 09:08 Thu, 20 Aug
Torrent Pharma Vs Mankind Pharma: Morgan Stanley flips preference, sees up to 40% upside in one stock The Financial Express 05:45 Mon, 03 Aug
Mankind Pharma shares fall 6% despite 30% Q1 Pat growth; here's why The Business Standard 10:27 Fri, 31 Jul
Mankind Pharma Q1 result: Profit rises 29.6% to ₹568 cr, revenue up 12.9% The Business Standard 11:37 Thu, 30 Jul
